Scientific Session Conference Abstracts
Scientific Session 1: New HIV
Enzyme Immunoassays
Scientific Session 2: NAAT Testing for Acute
HIV Infection
Scientific Session 3: Rapid HIV Testing
Scientific Session 4: Options for Confirmatory
Testing in Different Settings
Scientific Session 5: Dried Blood Spot Testing
Scientific Session 6: Concurrent Discussion Groups
Scientific Session 1: New HIV Enzyme Immunoassays
Principles and Characteristics of EIAs Recently
Approved by the FDA
- Vironostika HIV-1 Plus O Microelisa
System for the Detection of Antibodies to HIV-1, including Group
O
Speaker: Chamroen Chetty, PhD
Senior
manager Immunoassay R&D, bioMérieux Inc.
View
Abstract View
Presentation
- Principles and Characteristics of the
BIO-RAD Genetic Systems™ HIV-1/HIV-2 Plus O EIA
Speaker: M. Kathleen Shriver, PhD
R&D
Manager, Redmond Operations, Bio-Rad Laboratories
View Abstract View
Presentation
- Comparing the New EIAs with Old Standbys:
Validation Data from Public Health Laboratories
Speaker: Berry Bennett, MPH
Retrovirology
Section Chief, Florida
Bureau of Laboratories
View Abstract View
Presentation
- APHL Survey on HIV Assays Currently
in Use
Speaker: Barbara Werner, PhD
Infectious
Disease Consultant, Massachusetts
State Laboratory Institute
View Abstract View
Presentation
back to top
Scientific Session 2: NAAT Testing for Acute
HIV Infection
- Results of donor screening with nucleic
acid amplification tests (NAT) and implications for HIV research, diagnosis
and surveillance
Speaker: Michael P. Busch, MD, PhD
Professor
of Laboratory Medicine, UCSF
Director,
Blood Systems Research Institute
View Abstract View
Presentation
- Pooled RNA Testing of Antibody Negative High-Risk
Persons: San Francisco and Los Angeles
Speaker: Sally Liska, DrPH
Director,
San Francisco Public Health Laboratory
View Abstract View
Presentation
- Alternatives for Detecting Acute HIV: RNA, p24,
and heat-dissociated p24
Speaker: Christopher D.Pilcher, MD
Assistant
Professor of Medicine, University
of North Carolina at Chapel Hill
View Abstract View
Presentation
- HIV NAAT Testing of HIV Antibody Negative Samples
Speaker: Robert Myers PhD
Deputy
Director, Maryland
Dept of Health and Mental Hygiene Laboratories
View Abstract View
Presentation
- Screening for Primary HIV Infection: The CDC Study
Speaker: Pragna Patel, MD, MPH
Medical
Epidemiologist, Diagnostic Applications
Behavioral
and Clinical Surveillance Branch, CDC
View Abstract View
Presentation
back to top
Scientific Session 3: Rapid HIV Testing
- Panel: Roll-out and Implementation of Rapid Testing
from a Field Perspective
Speakers:
- Rapid HIV Testing: Implementation From a Field Perspective
Tony Falvo, CTL Program Coordinator, Florida
Bureau of HIV/AIDS
View Abstract View
Presentation
- Roll-out and Implementation of Rapid Testing from a
Field Perspective
Marianne Porter, BS MS, Director, Division of Laboratory
Improvement, Pennsylvania Department of Health
View Abstract View
Presentation
- Implementing Rapid HIV Testing in New York State
Mara San Antonio Gaddy,
RN, MSN, Director, Bureau of Direct Program Operations, New
York State Department of Health
View Abstract View
Presentation
- Implementation of Rapid Testing from a Rural Perspective - Keys
to Success
Susanne Norris Zanto, BS, CLS (NCA), Technical
Services Manager, Montana Public Health Laboratory
View Abstract View
Presentation
- Roll-out and Implementation of Rapid Testing from a Field Perspective
Shelley Facente,
MPH, HIV Rapid Testing Coordinator, San Francisco Department
of Public Health AIDS Office
View Abstract View
Presentation
- Resolution of Discordant Confirmatory Results after
POC Reactive Rapid Tests
Speaker: Berry Bennett, MPH
Retrovirology
Section Chief, Florida
Bureau of Laboratories
View Abstract View
Presentation
- Post Marketing Surveillance of OraQuick Rapid HIV
Testing
Speaker: Laura Wesolowski, MPH
Laboratory Determinants and diagnostics,
Behavioral and Clinical Surveillance Branch, CDC
View Abstract View
Presentation
- Evaluation and Implementation of HIV Rapid Tests:
The Experience in Eleven African Countries
Speaker: Stefan Wiktor, MD, MPH, Chief,
Surveillance
and Infrastructure Development Branch,
Global
AIDS Program, CDC
View Abstract View
Presentation
- Implications for the Public Health Laboratory from
Expansion of Rapid Testing
Speaker: Arthur Kazianis, BA
HIV/Hepatitis
Laboratory Supervisor, Massachusetts
Department of Public Health
View Abstract View
Presentation
back to top
Scientific Session 4: Options for Confirmatory Testing
in Different Settings
- Challenges for Blood Donor Confirmatory Testing
Algorithms
Speaker: Susan L. Stramer, PhD
Executive
Scientific Officer, American Red Cross
View Abstract View
Presentation
- Comparison of Currently Available Assays that Detect
Human Immunodeficiency Virus to Address Alternative Screening/Diagnostic
Algorithms for HIV
Speaker: S. Michele Owen, PhD
Chief
HIV Serology and Developmental Diagnostics Lab, CDC
View Abstract View
Presentation
- Performance of Rapid HIV Tests Singly and in Combination
Speaker: Kevin Delaney, MPH
Epidemiologist, Diagnostic Applications,
Behavioral and Clinical Surveillance Branch, CDC
View Abstract View
Presentation
- HIV 1/2 Combination Screening and Outcomes of Follow-Up
Speaker: William R. Oleszko, PhD
Acting Associate Director, Public Health Laboratory,
New York City Department of Health and Mental Hygiene
View Abstract View
Presentation
back to top
Scientific Session 5: Dried Blood Spot Testing
- Dried Blood Spots: An Ideal Specimen for HIV Serologic
and Nucleic Acid Testing
Speaker: Joanne Mei, PhD
Lead Research Chemist
Newborn Screening Quality Assurance Program, CDC
View Abstract View
Presentation
- Usefulness and Application of Dried Blood Spots
in HIV and HCV Epidemiology, Diagnostics and Drug Resistance Testing
Speaker: John Kim, PhD
Chief,
National HIV Reference Lab Public Health Agency of Canada
View Abstract View
Presentation
- Early Diagnosis of HIV-1 Infection in Infants Using
Dried Blood Spots and Real Time, RT-PCR
Speaker: Chin-Yih Ou, PhD
Chief,
HIV Molecular Diagnostics Lab, CD
View Abstract View
Presentation
- Use of DBS with BED Testing for Recent Infection
Speaker: Bharat S. Parekh, PhD
Chief,
HIV Incidence Laboratory, CDC
View Abstract View
Presentation
- Use of DBS for HIV Drug Resistance Surveillance
Speaker: Diane V. Bennett, MD, MPH, M.ED.
Coordinator,
Antiretroviral Drug Resistance Surveillance,
CDC
View Abstract View
Presentation
back to top
Scientific Session 6: Concurrent Discussion Groups
- Updates: Status of Tests for Recent Infection & CDC’s
Plans for the Detuned IND
Speaker: Bernie Branson, MD
Associate
Director for Laboratory Diagnostics, CDC
View Abstract View
Presentation
Panel: Tests for Recent Infection
Moderators: Niel Constantine
and Anne M. Sill
- Calibration, validation and application of the
BED assay for recent HIV-1 infection in multiple subtypes
Panelist: Bharat S. Parekh, PhD, Chief, HIV Incidence and Diagnosis Laboratory,
CDC
View Abstract View
Presentation
- A Simple and Inexpensive Algorithm for Determining
Recent HIV Infection: Development of a Sensitive/Less Sensitive (S/LS)
Particle Agglutination Assay
Panelist: Neil Constantine, PhD, Professor, University of Maryland School
of Medicine
View Abstract View
Presentation
- Identification of Factors Impacting the Determination
of HIV Incidence in Non-Research-Based, Clinical Populations
Panelist: Anne M. Sill, BA, Research Supervisor, Research
Associate, Institute of Human Virology,
View Abstract View
Presentation
- Incidence Tests for the Serological Testing Algorithm
for Recent HIV Seroconversion (STARHS)
Panelist: Joanne Mei, PhD, Lead Research Chemist, CDC,
View Abstract View
Presentation
- Summary of STARHS meeting in Bangkok
Panelist: Robert Remis, MD, MPH, FRCPC, Professor,
Public Health Sciences, University of Toronto, Canada
View Abstract View
Presentation
Panel: Rapid HIV Testing in International Settings
Moderator: Mark Rayfield, PhD, Global AIDS Program CDC
- Arguments for the use HIV Rapid Tests on a National Scale in Resource
Poor Settings
Panelist: Kyle B. Bond, MS, Surveillance and Infrastructure Development Branch,
GAP, NCHSTP, CDC
View Abstract View
Presentation
- HIV in Botswana; Improving Lab Capacity in the Face of
the AIDS Pandemic
Panelist: Patricia Clark, MPH, Interim Virology/Immunology
Section Manager, Michigan Department of Community Health
View Abstract View
Presentation
- Rapid Testing: The Kenya Experience
Panelist: Dr. Peter Tukei, Assistant Director Kenya Medical Research Institute,
Laboratory Director, CDC/KEMRI
View Abstract View
Presentation
- Use of Rapid HIV Assays in Vietnam and Cambodia: Challenges to improving
access, quality and timeliness of HIV Testing
Panelist: Ralph Timperi, MPH, Director Massachusetts State Laboratory Institutes
View Abstract View
Presentation
- Quality Assurance for Rapid Testing
Panelist: Elizabeth Dax, AM, MD, BS, PhD, Director, National Serology Reference
Laboratory, Australia
View Abstract View
Presentation
back to top
|
